国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
10期
1482-1484
,共3页
胃肠道肿瘤%围手术期%肠外营养%肠内营养
胃腸道腫瘤%圍手術期%腸外營養%腸內營養
위장도종류%위수술기%장외영양%장내영양
Gastrointestinal cancer%Perioperative%Parenteral nutrition%Enteral nutrition
目的 探讨围手术期不同营养支持方法对胃肠道肿瘤患者的影响.方法 我院2009年12月-2011年4月收治的70例胃肠道肿瘤患者随机分为PN组和EN组各35例,PN组患者给予肠外营养,EN组患者给予肠内营养.比较两组患者术后的营养状况.结果 PN组患者腹痛腹胀4例、恶心呕吐2例、无腹泻;EN组患者腹痛腹胀5例、恶心呕吐3例、腹泻2例.EN组患者术后血清总蛋白、前白蛋白、白蛋白和转铁蛋白均高于PN组(p<0.05).结论 对胃肠道肿瘤患者给予肠内营养,副作用少,改善营养状态更明显,是安全和更有效的营养供给方式,值得在临床应用.
目的 探討圍手術期不同營養支持方法對胃腸道腫瘤患者的影響.方法 我院2009年12月-2011年4月收治的70例胃腸道腫瘤患者隨機分為PN組和EN組各35例,PN組患者給予腸外營養,EN組患者給予腸內營養.比較兩組患者術後的營養狀況.結果 PN組患者腹痛腹脹4例、噁心嘔吐2例、無腹瀉;EN組患者腹痛腹脹5例、噁心嘔吐3例、腹瀉2例.EN組患者術後血清總蛋白、前白蛋白、白蛋白和轉鐵蛋白均高于PN組(p<0.05).結論 對胃腸道腫瘤患者給予腸內營養,副作用少,改善營養狀態更明顯,是安全和更有效的營養供給方式,值得在臨床應用.
목적 탐토위수술기불동영양지지방법대위장도종류환자적영향.방법 아원2009년12월-2011년4월수치적70례위장도종류환자수궤분위PN조화EN조각35례,PN조환자급여장외영양,EN조환자급여장내영양.비교량조환자술후적영양상황.결과 PN조환자복통복창4례、악심구토2례、무복사;EN조환자복통복창5례、악심구토3례、복사2례.EN조환자술후혈청총단백、전백단백、백단백화전철단백균고우PN조(p<0.05).결론 대위장도종류환자급여장내영양,부작용소,개선영양상태경명현,시안전화경유효적영양공급방식,치득재림상응용.
Objective To compare the two ways of perioperative nutritional support for gastrointestinal cancer patients.Methods 70 hospitalized gastrointestinal cancer patients from December 2009 to April 2011 were randomly allocated into two groups.35 patients were enrolled in each group,The control group (PN group) was given parenteral nutrition while the experimental group (EN group) was given enteral nutrition.The nutritional status was compared.Results (1) Adverse reactions:there were no significant difference (P>0.05) in adverse reactions including abdominal pain or bloating,nausea or vomiting,and diarrhea between the two groups:(2) Nutritional status:the experimental group patients got statistically better nutritional status (P<0.05) including postoperative serum total protein,prealbumin,albumin,and transferrin protein than the control group.Conclusion The enteral nutrition for gastrointestinal cancer patients can improve the nutritional status and has less adverse effects.It would be safer and more effective for clinical application.